Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results Westlake Village, CA, October 28, 2025 – Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today outlined its strategy to achieve sustainable growth and reported financial results for the quarter ended September 30, 2025. Arcutis will review both topics at its Investor Day, which begins today a ...